Stockreport

Cytokinetics Teases Q2 Phase 3 ACACIA-HCM Readout as Myqorzo Launch Gains Traction at Citi Conference [Yahoo! Finance]

Cytokinetics, Incorporated  (CYTK) 
Last cytokinetics, incorporated earnings: 3/3 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytokinetics.com/investor-overview
PDF HCM in Q2 and says NHCM could be roughly as large as OHCM (~100,000 U.S. patients), potentially giving the company a standalone position if approved. Myqorzo launch ga [Read more]